{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:57:20Z","timestamp":1787504240327,"version":"build-2736575974"},"reference-count":25,"publisher":"American Society of Consultant Pharmacists","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["sr care pharm"],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    The transition from hospital to home for older individuals can be complicated, as they are more likely to have complex health and\/or social care needs. Several published studies have outlined positive outcomes from pharmacist-driven transition of care programs.\n At our four geriatric primary care clinics affiliated with a large academic medical center, there is no medication reconciliation process to evaluate a patient\u2019s medications after being discharged from the hospital to home.\n                    <jats:bold>Objective:<\/jats:bold>\n                    The objective of this pilot program\n was to demonstrate the need for a pharmacist-led transition of care medication reconciliation program within a geriatric primary care setting.\n                    <jats:bold>Design:<\/jats:bold>\n                    This is a retrospective evaluation of a pilot program that took place from July 1, 2022, to June 30, 2023, within 4 geriatric\n primary care clinics affiliated with a 523-bed, full-service medical and surgical acute care hospital. Electronic medical records (EMR) were utilized to identify patients who were discharged from the hospital within 24 to 72 hours to their homes. Documentation in the patient\u2019s EMR by\n the primary care clinic\u2019s clinical pharmacist contained confirmation of a hospital follow-up appointment, completion of medication reconciliation, notification to the provider for pharmacotherapy concerns, and patient counseling on medication changes. Information on number of patients\n requiring clinical pharmacist intervention prior to hospital follow-up appointment, intervention type, average number of medication discrepancies per patient, and percentage of hospital follow-up appointments with a medication reconciliation completed prior to visit were also documented.\n                    <jats:bold>Setting:<\/jats:bold>\n                    Four geriatric primary care clinics affiliated with a 523-bed, full-service medical and surgical acute care hospital in Gainesville, Florida.\n                    <jats:bold>Patients, Participants:<\/jats:bold>\n                    A total of 881 unique medication reconciliations were completed for this retrospective\n pilot program study. Patients were included if they were discharged from the hospital to home during that time period and were active patients of a provider at the primary care clinic. Patients were excluded if they were discharged from the hospital to another acute care facility (such as\n a skilled nursing facility, rehabilitation facility, or hospice), if the patient expired during their hospitalization, or if they were not an active patient of a provider at the primary care clinic.\n                    <jats:bold>Intervention:<\/jats:bold>\n                    A primary care clinical pharmacist reviewed each discharged\n patient\u2019s EMR from the hospital to reconcile their medications with the medication list within the patient\u2019s primary care EMR. A transitions of care medication reconciliation evaluation progress note was created for each patient discharged home for documentation. Within this note,\n the pharmacist documented the number of medication discrepancies, medications added, medications discontinued, and medications with dosage adjustments. The pharmacist would contact the patient to clarify any urgent medication concerns and confirm that they made the appropriate medication adjustments\n as instructed at discharge from the hospital. If the clinical pharmacist had additional pharmacotherapy concerns, they would contact the provider prior to the hospital follow-up appointment. This was counted as an intervention. The intervention type was classified into categories based on\n the issue as determined by the clinical pharmacist: new medication, medication omission, high-risk medication, clarify administration frequency, clarify dose, and other reasons.\n                    <jats:bold>Methods:<\/jats:bold>\n                    Data from EMRs identified patients discharged home from the hospital within the last\n 24-72 hours between July 1, 2022, and June 30, 2023. Medication reconciliation was documented in the patient\u2019s EMR. The following elements were included: confirmation of a hospital follow-up appointment, notification to the provider for pharmacotherapy concerns, and patient counseling\n on medication changes.\n                    <jats:bold>Results:<\/jats:bold>\n                    A total of 881 patient evaluations were included in this study; and these evaluations identified 4,895 medication discrepancies with an average of 5.5 discrepancies per patient. Prior to the hospital follow-up appointment, 267 patients (30.3%)\n required clinical pharmacist intervention. By the end of the study period, 96.3% of hospital follow-up appointments had a medication reconciliation completed by a clinical pharmacist prior to the visit.\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    This pharmacist-led medication reconciliation program within\n a geriatric primary care setting confirms a gap in care during transition from hospital to home. It was able to identify medication discrepancies and educate patients about medication changes.\n                  <\/jats:p>","DOI":"10.4140\/tcp.n.2025.217","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T03:29:43Z","timestamp":1745897383000},"page":"217-222","source":"Crossref","is-referenced-by-count":2,"title":["Medication Reconciliation at Transition of Care in a Geriatric Primary Care Setting: A Pilot Program"],"prefix":"10.4140","volume":"40","author":[{"given":"Kimberly","family":"Atkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Koff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilyarosa Perez","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Rhein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2625","reference":[{"key":"ref1","article-title":"Transitions of Care. Agency for Healthcare Research and Quality.","year":"2018","journal-title":"Rockville, MD."},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jama.1997.03540280045032","article-title":"The costs of adverse drug events in hospitalized patients.","volume":"277","journal-title":"JAMA."},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.1995.03530010049034","article-title":"Systems analysis of adverse drug events.","volume":"274","journal-title":"JAMA."},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jama.1995.03530010043033","article-title":"Incidence of adverse drug events and potential adverse drug events: implications for prevention.","volume":"274","journal-title":"JAMA."},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archinte.163.12.1461","article-title":"Medication errors in hospitalized cardiovascular patients.","volume":"163","journal-title":"Arch Intern Med."},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1017\/S0959259815000064","article-title":"Hospital readmissions in frail older people.","volume":"25","journal-title":"Rev in Clin Gerontol."},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.sapharm.2017.01.006","article-title":"Informational needs and recall of in-hospital medication changes of recently discharged patients,","volume":"14","journal-title":"Res Social Adm Pharm."},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jhm.668","article-title":"Problems after discharge and understanding of communication with their primary care physicians among hospitalized seniors: a mixed methods study.","volume":"5","journal-title":"J Hosp Med."},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/hex.13145","article-title":"Post-discharge medicines management: the experiences, perceptions and roles of older people and their family carers.","volume":"23","journal-title":"Health Expectations."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2147\/TCRM.S109214","article-title":"How does hospitalization affect continuity of drug therapy: an exploratory study.","volume":"12","journal-title":"Ther Clin Risk Manag."},{"key":"ref11","first-page":"1","article-title":"Assessment of requests for medication-related follow-up after hospital discharge, and the relation to unplanned hospital revisits, in older patients: a multicentre retrospective chart review.","volume":"21","journal-title":"BMC Geriatrics."},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2042098619858049","DOI":"10.1177\/2042098619858049","article-title":"Frequency of undocumented medication discrepancies in discharge letters after hospitalization of older patients: a clinical record review study.","volume":":10","year":"2019","journal-title":"Ther Adv Drug Saf"},{"key":"ref13","first-page":"1","article-title":"Delivering exceptionally safe transitions of care to older people: a qualitative study of multidisciplinary staff perspectives.","volume":"20","journal-title":"BMC Health Serv Res."},{"issue":"3","key":"ref14","first-page":"345","article-title":"Adverse events among medical patients after discharge from hospital.","volume":"170","journal-title":"CMAJ."},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-138-3-200302040-00007","article-title":"The incidence and severity of adverse events affecting patients after discharge from the hospital.","volume":"138","journal-title":"Ann Intern Med."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1525-1497.2005.30390.x","article-title":"Adverse drug events occurring following hospital discharge.","volume":"20","journal-title":"J Gen Intern Med."},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1525-1497.2003.20722.x","article-title":"Medical errors related to discontinuity of care from an inpatient to an outpatient setting.","volume":"18","journal-title":"J Gen Intern Med."},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1093\/ajhp\/zxad306","article-title":"Evaluation of the impact of a pharmacy transitions of care program.","volume":"81","journal-title":"Am J Health Syst Pharm."},{"issue":"16","key":"ref19","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1056\/NEJMsa020703","article-title":"Adverse drug events in ambulatory care.","volume":"348","journal-title":"N Engl J Med."},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archinte.166.5.565","article-title":"Role of pharmacist counseling in preventing adverse drug events after hospitalization.","volume":"166","journal-title":"Arch Intern Med."},{"issue":"21","key":"ref21","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/archinternmed.2009.398","article-title":"Impact of a pharmacist-facilitated hospital discharge program: a quasi-experimental study.","volume":"169","journal-title":"Arch Intern Med."},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1532-5415.2003.51186.x","article-title":"American Geriatrics Society Health Care Systems Committee. Improving the quality of transitional care for persons with complex care needs.","volume":"51","journal-title":"J Am Geriatr Soc."},{"issue":"17","key":"ref23","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1001\/archinte.166.17.1822","article-title":"The care transitions intervention: results of a randomized controlled trial.","volume":"166","journal-title":"Arch Intern Med."},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archinte.166.5.565","article-title":"Role of pharmacist counseling in preventing adverse drug events after hospitalization.","volume":"166","journal-title":"Arch Intern Med."},{"issue":"9B","key":"ref25","first-page":"26S","article-title":"The impact of follow-up telephone calls to patients after hospitalization.","volume":"111","year":"2001","journal-title":"Disease-a-month : DM, 48(4), 239\u2013248. Am J Med."}],"container-title":["The Senior Care Pharmacist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ascp\/tscp\/2025\/00000040\/00000005\/art00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:32:03Z","timestamp":1782534723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.4140\/TCP.n.2025.217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"alternative-id":["2639-9636(20250501)40:5L.217;1-"],"URL":"https:\/\/doi.org\/10.4140\/tcp.n.2025.217","relation":{},"ISSN":["2639-9636"],"issn-type":[{"value":"2639-9636","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}